Antiglobulins, cryoglobulins and glomerulonephritis: Second International Milano Meeting of Nephrology 30 September – 1 October 1985: Developments in Nephrology, cartea 16
Editat de G. Ponticelli, Luigi Minetti, G. D'Amicoen Limba Engleză Paperback – 5 oct 2011
Din seria Developments in Nephrology
- 5% Preț: 1564.90 lei
- 5% Preț: 1377.19 lei
- 5% Preț: 698.44 lei
- 5% Preț: 1378.07 lei
- 5% Preț: 1377.73 lei
- 5% Preț: 1868.95 lei
- 5% Preț: 354.52 lei
- 5% Preț: 1066.95 lei
- 5% Preț: 1395.50 lei
- 5% Preț: 366.78 lei
- 5% Preț: 701.45 lei
- 5% Preț: 1378.43 lei
- 5% Preț: 359.49 lei
- 5% Preț: 359.69 lei
- 5% Preț: 374.60 lei
- 5% Preț: 361.60 lei
- 5% Preț: 1381.29 lei
- 5% Preț: 366.96 lei
- 5% Preț: 692.76 lei
- 5% Preț: 2290.37 lei
- 5% Preț: 371.55 lei
- 5% Preț: 2064.65 lei
- 5% Preț: 1072.07 lei
- 5% Preț: 1382.70 lei
- 5% Preț: 1374.86 lei
- 5% Preț: 377.07 lei
- 5% Preț: 354.72 lei
- 5% Preț: 362.71 lei
- 5% Preț: 362.49 lei
- 5% Preț: 1063.92 lei
- 5% Preț: 360.74 lei
- 5% Preț: 1066.75 lei
Preț: 359.33 lei
Preț vechi: 378.24 lei
-5% Nou
Puncte Express: 539
Preț estimativ în valută:
68.78€ • 71.68$ • 57.25£
68.78€ • 71.68$ • 57.25£
Carte tipărită la comandă
Livrare economică 06-20 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9789401084062
ISBN-10: 9401084068
Pagini: 316
Ilustrații: 314 p.
Dimensiuni: 155 x 235 x 17 mm
Greutate: 0.45 kg
Ediția:Softcover reprint of the original 1st ed. 1986
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Developments in Nephrology
Locul publicării:Dordrecht, Netherlands
ISBN-10: 9401084068
Pagini: 316
Ilustrații: 314 p.
Dimensiuni: 155 x 235 x 17 mm
Greutate: 0.45 kg
Ediția:Softcover reprint of the original 1st ed. 1986
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Developments in Nephrology
Locul publicării:Dordrecht, Netherlands
Public țintă
ResearchCuprins
I. Physiology and Pathology of Antiglobulins.- 1. Subsets of Rheumatoid Factors Determined by Cross Idiotypes.- 2. Structure and Function of Rheumatoid Factors: Implication For Its Role in The Pathogenesis of Mixed Cryoglobulinemia.- 3. Regulatory Idiotypes and Diseases.- II. Role of Antiglobulins in Experimental Glomerulonephritis.- 4. Pathogenetic Mechanisms of Infective Endocarditis Glomerulonephritis in The Rabbit.- 5. Interactions of Human IgM Rheumatoid Factors With Immune Complexes in Experimental Murine Glomerulonephritis.- 6. Anti-Idiotypic Antibodies in Glomerulonephritis and in Tubulointerstitial Nephritis Models in Immune Renal Injury.- 7. Experimental Analysis of The Generation of Pathogenic Immune Complexes Resulting From Immunoglobulin Interactions.- III. Classification of Cryoglobulins and Biochemical Factors Inducing Cryoprecipitation.- 8. Classification of Cryoglobulinemias.- 9. Intrinsic Properties Inducing Precipitation of Cryoglobulins.- 10. Cryoprecipitation as a Consequence of Globulin-Antiglobulin Interactions.- 11. Fibronectin Is a Regular Component of Single-Type and Mixed Cryoglobulins.- IV. Immunological Aspects of Essential Mixed Cryoglobulinemia.- 12. Complement Activation in Patients With Mixed Cryoglobulinemia.- 13. Human Type II Mixed Cryoglobulins as a Model of Idiotypic Interactions.- 14. Monoclonal Antibodies to Idiotypic Determinants on Monoclonal Rheumatoid Factors.- V. Clinical and Morphological Findings in Essential Mixed Cryoglobulinemia.- 15. Mixed Cryoglobulinemia: An Update of Recent Clinical Experience.- 16. Histological and Himmunohistological Features in Essential Mixed Cryoglobulinemia Glomerulonephritis.- 17. Clinical and Histological Correlations in Essential Mixed Cryoglobulinemia (EMC) Glomerulonephritis.- 18. Ultrastructural Features in Glomerulonephritis in Essential Mixed Cryoglobulinemia.- 19. Prognostic Factors in Essential Mixed Cryoglobulinemia Nephropathy.- VI. Different Therapeutic Regimens in the Management of EMC Patients.- 20. Long-Term Management of Essential Mixed Cryoglobulinemia.- 21. Effects of Cryoapheresis on Plasma Cryoglobulins and Renal Function in Patients With EMC Glomerulonephritis.- 22. Treatment of Renal Disease in Essential Mixed Cryoglobulinemia.- 23. Long Term Treatment of Mixed Cryoglobulinemia (MCG).- Concluding remarks.